T1	Participants 303 336	moderate and severe endometriosis
T2	Participants 467 500	patients treated with triptorelin
T3	Participants 647 793	Forty patients after their first conservative operation for endometriosis, with surgical confirmation of revised AFS stage III or IV endometriosis
